Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Andrew Moreo; Lenore Giannunzio

Andelyn Biosciences

Gene Therapy

Changing Lives, One Patient at a Time

Andelyn Biosciences

Expansion

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

Andelyn Biosciences

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

Gene Therapy Manufacturing

Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing

Wade Macedone; Adam Lauber

Andelyn Biosciences

Cell and Gene Therapy

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

Cyrill Kellerhals; Sarah O'Reilly

Andelyn Biosciences

Viral Vectors

Navigating Analytical Requirements for GMP Viral Vectors

Will Fountain

Andelyn Biosciences

Gene Therapy

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

Wade Macedone; Jonathan Rush; Phillip Vermilion; Samir Acharya, Ph.D.

Andelyn Biosciences

Gene Therapy

Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances

Wade Macedone; Mayo Pujols

Andelyn Biosciences